S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:DLMAF

Dollarama (DLMAF) Stock Price, News & Analysis

$82.64
+1.16 (+1.42%)
(As of 04/18/2024 ET)
Today's Range
$82.64
$82.64
50-Day Range
$72.92
$84.03
52-Week Range
$60.02
$84.20
Volume
895 shs
Average Volume
9,701 shs
Market Capitalization
N/A
P/E Ratio
40.53
Dividend Yield
0.38%
Price Target
$60.20

Dollarama MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
27.2% Downside
$60.20 Price Target
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.97
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.27 out of 5 stars

DLMAF stock logo

About Dollarama Stock (OTCMKTS:DLMAF)

Dollarama Inc. operates a chain of dollar stores in Canada. Its stores offer general merchandise, consumables, and seasonal products. It also sells its products through online store. The company was formerly known as Dollarama Capital Corporation and changed its name to Dollarama Inc. in September 2009. Dollarama Inc. was founded in 1992 and is headquartered in Mount Royal, Canada.

DLMAF Stock Price History

DLMAF Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Scotiabank Keeps Their Hold Rating on Dollarama (DLMAF)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Dollarama: Strong Buy on Competitive Edge and Growth Prospects
See More Headlines
Receive DLMAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dollarama and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/05/2013
Today
4/19/2024
Next Earnings (Estimated)
6/05/2024

Industry, Sector and Symbol

Industry
Discount Stores
Sub-Industry
N/A
Current Symbol
OTCMKTS:DLMAF
CIK
N/A
Fax
N/A
Employees
8,440
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$60.20
High Stock Price Target
$68.00
Low Stock Price Target
$48.00
Potential Upside/Downside
-27.2%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Neil Rossy (Age 54)
    CEO, President & Director
    Comp: $4.34M
  • Ms. Johanne Choinière
    Chief Operating Officer
  • Mr. Nicolas Hien
    Chief Information Officer
  • Mr. Geoffrey Robillard (Age 65)
    Senior Vice President of Import Division
    Comp: $1.5M
  • Mr. Laurence Rossy (Age 81)
    Founder & Chairman Emeritus
    Comp: $503.73k
  • Mr. Patrick Bui
    Chief Financial Officer
  • Laurence L'Abbe
    Senior VP of Legal Affairs & Corporate Secretary
  • Mark Di Pesa
    Senior Vice President of Human Resources
  • Mr. Michael Ross A.C.A. (Age 64)
    F.C.A., FCPA, Special Advisor
    Comp: $434.59k
  • Mr. Jean-Philippe Durivage-Lachance
    VP & Treasurer

DLMAF Stock Analysis - Frequently Asked Questions

What is Dollarama's stock price target for 2024?

0 Wall Street analysts have issued 1 year price objectives for Dollarama's stock. Their DLMAF share price targets range from $48.00 to $68.00. On average, they anticipate the company's stock price to reach $60.20 in the next twelve months. This suggests that the stock has a possible downside of 27.2%.
View analysts price targets for DLMAF
or view top-rated stocks among Wall Street analysts.

How have DLMAF shares performed in 2024?

Dollarama's stock was trading at $71.81 at the beginning of the year. Since then, DLMAF stock has increased by 15.1% and is now trading at $82.6430.
View the best growth stocks for 2024 here
.

Are investors shorting Dollarama?

Dollarama saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 377,400 shares, an increase of 47.1% from the March 15th total of 256,500 shares. Based on an average daily trading volume, of 8,400 shares, the days-to-cover ratio is presently 44.9 days.
View Dollarama's Short Interest
.

When is Dollarama's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 5th 2024.
View our DLMAF earnings forecast
.

How were Dollarama's earnings last quarter?

Dollarama Inc. (OTCMKTS:DLMAF) issued its earnings results on Thursday, December, 5th. The company reported $0.29 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by $0.00.

Is Dollarama a good dividend stock?

Dollarama (OTCMKTS:DLMAF) pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.61%. The dividend payout ratio is 15.20%. This payout ratio is at a healthy, sustainable level, below 75%.

When did Dollarama's stock split?

Dollarama shares split before market open on Wednesday, June 20th 2018. The 3-1 split was announced on Thursday, June 7th 2018. The newly issued shares were payable to shareholders after the market closes on Tuesday, June 19th 2018. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

How do I buy shares of Dollarama?

Shares of DLMAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DLMAF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners